# Cancer immunoediting: from immunosurveillance to tumor escape

Source: https://onco.cc/key-papers/paper-dunn-nat-immunol/  
OnCo record `paper-dunn-nat-immunol` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Paper cited by one term page, indexed on Europe PMC as PubMed record 12407406 and published in Nature immunology; the citing page links this DOI, which is how the record was matched.

## Summary

The concept that the immune system can recognize and destroy nascent transformed cells was originally embodied in the cancer immunosurveillance hypothesis of Burnet and Thomas. This hypothesis was abandoned shortly afterwards because of the absence of strong experimental evidence supporting the concept. New data, however, clearly show the existence of cancer immunosurveillance and also indicate that it may function as a component of a more general process of cancer immunoediting. This process is responsible for both eliminating tumors and sculpting the immunogenic phenotypes of tumors that eventually form in immunocompetent hosts. In this review, we will summarize the historical and experimental basis of cancer immunoediting and discuss its dual roles in promoting host protection against cancer and facilitating tumor escape from immune destruction.

Indexed on Europe PMC as PubMed record 12407406 (DOI 10.1038/ni1102-991). Matched by DOI alone: one term page cites this DOI among its external links (the pages are listed under Related), and this page was written so that the citation resolves inside OnCo. No figure has been checked by an editor.

## Fields

- Kind: Key paper
- Last checked: 2026-09-22
- Tags: europepmc-ingest
- Journal: Nature immunology
- Year: 2002
- DOI: 10.1038/ni1102-991
- Authors: Dunn GP, Bruce AT, Ikeda H, et al.
- What it means: One term page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
- Caveats: Matched to the citing OnCo records by DOI alone; the summary reproduces the Europe PMC abstract and no figure has been verified against the full paper.

## Sources

- Nat Immunol 2002: https://doi.org/10.1038/ni1102-991
- PubMed: https://pubmed.ncbi.nlm.nih.gov/12407406/
- Europe PMC: https://europepmc.org/article/MED/12407406

## Connected records

- terms: [Immune surveillance and cancer immunoediting](https://onco.cc/terms/immune-surveillance-immunoediting/)

---
JSON: https://onco.cc/api/v1/entities/paper-dunn-nat-immunol.json